(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-2.90% $ 0.640
Live Chart Being Loaded With Signals
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc)...
Stats | |
---|---|
Dzisiejszy wolumen | 23 537.00 |
Średni wolumen | 220 504 |
Kapitalizacja rynkowa | 9.09M |
EPS | $0 ( 2024-03-07 ) |
Następna data zysków | ( $-0.200 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.310 |
ATR14 | $0.0120 (1.89%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-14 | Darvish Nissim | Buy | 20 572 | Option to Purchase American Depositary Shares |
2021-04-19 | Darvish Nissim | Buy | 11 884 | Option to Purchase American Depositary Shares |
2016-10-28 | Darvish Nissim | Buy | 10 123 | Option to Purchase American Depositary Shares |
2023-03-16 | Darvish Nissim | Buy | 6 857 | Option to Purchase American Depositary Shares |
2022-03-07 | Darvish Nissim | Buy | 6 820 | Option to Purchase American Depositary Shares |
INSIDER POWER |
---|
-57.70 |
Last 88 transactions |
Buy: 2 375 207 | Sell: 4 584 307 |
Anchiano Therapeutics Ltd Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SNGX | 0.895 |
LAWS | 0.894 |
NAKD | 0.892 |
DTSS | 0.891 |
CFMS | 0.886 |
IMV | 0.885 |
TNGX | 0.883 |
PIXY | 0.883 |
DBGI | 0.875 |
MRNA | 0.875 |
10 Najbardziej negatywne korelacje | |
---|---|
SJ | -0.906 |
MLTX | -0.893 |
ACVA | -0.893 |
PEGA | -0.888 |
KIN | -0.886 |
TA | -0.885 |
NCAC | -0.883 |
CONX | -0.879 |
NEO | -0.877 |
MYNA | -0.876 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Anchiano Therapeutics Ltd Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-66 827.00 (0.00 %) |
EPS: | $-2.06 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-66 827.00 (0.00 %) |
EPS: | $-2.06 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-57 773.00 (0.00 %) |
EPS: | $-2.43 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.200 |
Financial Reports:
No articles found.
Anchiano Therapeutics Ltd
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej